nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifaximin—NR1I2—Docetaxel—melanoma	0.61	0.734	CbGbCtD
Rifaximin—CYP3A4—Temozolomide—melanoma	0.127	0.153	CbGbCtD
Rifaximin—CYP3A4—Vemurafenib—melanoma	0.0697	0.0839	CbGbCtD
Rifaximin—CYP3A4—Docetaxel—melanoma	0.0239	0.0288	CbGbCtD
Rifaximin—Dysphagia—Temozolomide—melanoma	0.000741	0.00439	CcSEcCtD
Rifaximin—Pneumonia—Dactinomycin—melanoma	0.000735	0.00435	CcSEcCtD
Rifaximin—Sweating increased—Temozolomide—melanoma	0.000722	0.00427	CcSEcCtD
Rifaximin—Neutropenia—Carmustine—melanoma	0.000717	0.00424	CcSEcCtD
Rifaximin—Decreased appetite—Vemurafenib—melanoma	0.000717	0.00424	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Vemurafenib—melanoma	0.000712	0.00421	CcSEcCtD
Rifaximin—Fatigue—Vemurafenib—melanoma	0.000711	0.00421	CcSEcCtD
Rifaximin—Haemoglobin—Bleomycin—melanoma	0.000707	0.00418	CcSEcCtD
Rifaximin—Constipation—Vemurafenib—melanoma	0.000705	0.00417	CcSEcCtD
Rifaximin—Haemorrhage—Bleomycin—melanoma	0.000703	0.00416	CcSEcCtD
Rifaximin—Hypoaesthesia—Bleomycin—melanoma	0.000699	0.00414	CcSEcCtD
Rifaximin—Dysuria—Temozolomide—melanoma	0.000693	0.0041	CcSEcCtD
Rifaximin—Neutropenia—Temozolomide—melanoma	0.000693	0.0041	CcSEcCtD
Rifaximin—Hyperglycaemia—Carmustine—melanoma	0.000692	0.00409	CcSEcCtD
Rifaximin—Upper respiratory tract infection—Temozolomide—melanoma	0.000689	0.00408	CcSEcCtD
Rifaximin—Pneumonia—Carmustine—melanoma	0.000687	0.00407	CcSEcCtD
Rifaximin—Pollakiuria—Temozolomide—melanoma	0.000684	0.00405	CcSEcCtD
Rifaximin—Depression—Carmustine—melanoma	0.000682	0.00404	CcSEcCtD
Rifaximin—Photosensitivity reaction—Temozolomide—melanoma	0.000676	0.004	CcSEcCtD
Rifaximin—Weight increased—Temozolomide—melanoma	0.000674	0.00399	CcSEcCtD
Rifaximin—Weight decreased—Temozolomide—melanoma	0.00067	0.00397	CcSEcCtD
Rifaximin—Hyperglycaemia—Temozolomide—melanoma	0.000668	0.00396	CcSEcCtD
Rifaximin—Pneumonia—Temozolomide—melanoma	0.000664	0.00393	CcSEcCtD
Rifaximin—Infestation NOS—Temozolomide—melanoma	0.000661	0.00391	CcSEcCtD
Rifaximin—Infestation—Temozolomide—melanoma	0.000661	0.00391	CcSEcCtD
Rifaximin—Depression—Temozolomide—melanoma	0.000659	0.0039	CcSEcCtD
Rifaximin—Flushing—Bleomycin—melanoma	0.000652	0.00386	CcSEcCtD
Rifaximin—Body temperature increased—Vemurafenib—melanoma	0.000652	0.00386	CcSEcCtD
Rifaximin—Pharyngitis—Dactinomycin—melanoma	0.000651	0.00385	CcSEcCtD
Rifaximin—Haemoglobin—Carmustine—melanoma	0.000617	0.00365	CcSEcCtD
Rifaximin—Haemorrhage—Carmustine—melanoma	0.000614	0.00363	CcSEcCtD
Rifaximin—Hypoaesthesia—Carmustine—melanoma	0.000611	0.00361	CcSEcCtD
Rifaximin—Hot flush—Docetaxel—melanoma	0.000609	0.00361	CcSEcCtD
Rifaximin—Flushing—Dactinomycin—melanoma	0.000608	0.0036	CcSEcCtD
Rifaximin—Hypersensitivity—Vemurafenib—melanoma	0.000607	0.0036	CcSEcCtD
Rifaximin—Oedema peripheral—Carmustine—melanoma	0.000604	0.00358	CcSEcCtD
Rifaximin—Menopausal symptoms—Docetaxel—melanoma	0.000604	0.00358	CcSEcCtD
Rifaximin—Haemoglobin—Temozolomide—melanoma	0.000596	0.00353	CcSEcCtD
Rifaximin—Haemorrhage—Temozolomide—melanoma	0.000593	0.00351	CcSEcCtD
Rifaximin—Asthenia—Vemurafenib—melanoma	0.000591	0.0035	CcSEcCtD
Rifaximin—Hypoaesthesia—Temozolomide—melanoma	0.00059	0.00349	CcSEcCtD
Rifaximin—Pharyngitis—Temozolomide—melanoma	0.000589	0.00348	CcSEcCtD
Rifaximin—Urinary tract disorder—Temozolomide—melanoma	0.000586	0.00347	CcSEcCtD
Rifaximin—Oedema peripheral—Temozolomide—melanoma	0.000584	0.00346	CcSEcCtD
Rifaximin—Pruritus—Vemurafenib—melanoma	0.000583	0.00345	CcSEcCtD
Rifaximin—Urethral disorder—Temozolomide—melanoma	0.000581	0.00344	CcSEcCtD
Rifaximin—Hyponatraemia—Docetaxel—melanoma	0.000572	0.00339	CcSEcCtD
Rifaximin—Pain in extremity—Docetaxel—melanoma	0.00057	0.00337	CcSEcCtD
Rifaximin—Flushing—Carmustine—melanoma	0.000569	0.00337	CcSEcCtD
Rifaximin—Ill-defined disorder—Bleomycin—melanoma	0.000568	0.00336	CcSEcCtD
Rifaximin—Anaemia—Bleomycin—melanoma	0.000566	0.00335	CcSEcCtD
Rifaximin—Diarrhoea—Vemurafenib—melanoma	0.000564	0.00334	CcSEcCtD
Rifaximin—Migraine—Docetaxel—melanoma	0.000561	0.00332	CcSEcCtD
Rifaximin—Tinnitus—Temozolomide—melanoma	0.000553	0.00327	CcSEcCtD
Rifaximin—Malaise—Bleomycin—melanoma	0.000552	0.00327	CcSEcCtD
Rifaximin—Flushing—Temozolomide—melanoma	0.00055	0.00326	CcSEcCtD
Rifaximin—Dizziness—Vemurafenib—melanoma	0.000545	0.00323	CcSEcCtD
Rifaximin—Angiopathy—Temozolomide—melanoma	0.000538	0.00319	CcSEcCtD
Rifaximin—Mental disorder—Carmustine—melanoma	0.000538	0.00318	CcSEcCtD
Rifaximin—Mediastinal disorder—Temozolomide—melanoma	0.000534	0.00316	CcSEcCtD
Rifaximin—Malnutrition—Carmustine—melanoma	0.000534	0.00316	CcSEcCtD
Rifaximin—Cough—Bleomycin—melanoma	0.000534	0.00316	CcSEcCtD
Rifaximin—Dehydration—Docetaxel—melanoma	0.00053	0.00314	CcSEcCtD
Rifaximin—Ill-defined disorder—Dactinomycin—melanoma	0.00053	0.00314	CcSEcCtD
Rifaximin—Anaemia—Dactinomycin—melanoma	0.000527	0.00312	CcSEcCtD
Rifaximin—Vomiting—Vemurafenib—melanoma	0.000524	0.0031	CcSEcCtD
Rifaximin—Myalgia—Bleomycin—melanoma	0.000521	0.00308	CcSEcCtD
Rifaximin—Chest pain—Bleomycin—melanoma	0.000521	0.00308	CcSEcCtD
Rifaximin—Abdominal pain upper—Docetaxel—melanoma	0.000521	0.00308	CcSEcCtD
Rifaximin—Rash—Vemurafenib—melanoma	0.00052	0.00308	CcSEcCtD
Rifaximin—Mental disorder—Temozolomide—melanoma	0.000519	0.00308	CcSEcCtD
Rifaximin—Dermatitis—Vemurafenib—melanoma	0.000519	0.00307	CcSEcCtD
Rifaximin—Back pain—Carmustine—melanoma	0.000517	0.00306	CcSEcCtD
Rifaximin—Headache—Vemurafenib—melanoma	0.000516	0.00306	CcSEcCtD
Rifaximin—Malnutrition—Temozolomide—melanoma	0.000516	0.00306	CcSEcCtD
Rifaximin—Discomfort—Bleomycin—melanoma	0.000515	0.00305	CcSEcCtD
Rifaximin—Malaise—Dactinomycin—melanoma	0.000515	0.00305	CcSEcCtD
Rifaximin—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000513	0.00304	CcSEcCtD
Rifaximin—Nasopharyngitis—Docetaxel—melanoma	0.00051	0.00302	CcSEcCtD
Rifaximin—Confusional state—Bleomycin—melanoma	0.000504	0.00298	CcSEcCtD
Rifaximin—Tremor—Carmustine—melanoma	0.0005	0.00296	CcSEcCtD
Rifaximin—Anaphylactic shock—Bleomycin—melanoma	0.000499	0.00296	CcSEcCtD
Rifaximin—Back pain—Temozolomide—melanoma	0.000499	0.00296	CcSEcCtD
Rifaximin—Infection—Bleomycin—melanoma	0.000496	0.00294	CcSEcCtD
Rifaximin—Anaemia—Carmustine—melanoma	0.000494	0.00292	CcSEcCtD
Rifaximin—Dysphagia—Docetaxel—melanoma	0.000493	0.00292	CcSEcCtD
Rifaximin—Nausea—Vemurafenib—melanoma	0.00049	0.0029	CcSEcCtD
Rifaximin—Myalgia—Dactinomycin—melanoma	0.000486	0.00288	CcSEcCtD
Rifaximin—Tremor—Temozolomide—melanoma	0.000484	0.00286	CcSEcCtD
Rifaximin—Discomfort—Dactinomycin—melanoma	0.00048	0.00284	CcSEcCtD
Rifaximin—Ill-defined disorder—Temozolomide—melanoma	0.000479	0.00284	CcSEcCtD
Rifaximin—Anaemia—Temozolomide—melanoma	0.000477	0.00282	CcSEcCtD
Rifaximin—Anorexia—Bleomycin—melanoma	0.000476	0.00282	CcSEcCtD
Rifaximin—Angioedema—Temozolomide—melanoma	0.000472	0.00279	CcSEcCtD
Rifaximin—Hypotension—Bleomycin—melanoma	0.000467	0.00276	CcSEcCtD
Rifaximin—Malaise—Temozolomide—melanoma	0.000465	0.00276	CcSEcCtD
Rifaximin—Vertigo—Temozolomide—melanoma	0.000464	0.00275	CcSEcCtD
Rifaximin—Infection—Dactinomycin—melanoma	0.000463	0.00274	CcSEcCtD
Rifaximin—Neutropenia—Docetaxel—melanoma	0.000461	0.00273	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Bleomycin—melanoma	0.000455	0.00269	CcSEcCtD
Rifaximin—Myalgia—Carmustine—melanoma	0.000455	0.00269	CcSEcCtD
Rifaximin—Chest pain—Carmustine—melanoma	0.000455	0.00269	CcSEcCtD
Rifaximin—Cough—Temozolomide—melanoma	0.00045	0.00267	CcSEcCtD
Rifaximin—Weight increased—Docetaxel—melanoma	0.000448	0.00265	CcSEcCtD
Rifaximin—Weight decreased—Docetaxel—melanoma	0.000446	0.00264	CcSEcCtD
Rifaximin—Dyspnoea—Bleomycin—melanoma	0.000445	0.00264	CcSEcCtD
Rifaximin—Anorexia—Dactinomycin—melanoma	0.000444	0.00263	CcSEcCtD
Rifaximin—Pneumonia—Docetaxel—melanoma	0.000442	0.00262	CcSEcCtD
Rifaximin—Confusional state—Carmustine—melanoma	0.00044	0.0026	CcSEcCtD
Rifaximin—Arthralgia—Temozolomide—melanoma	0.000439	0.0026	CcSEcCtD
Rifaximin—Myalgia—Temozolomide—melanoma	0.000439	0.0026	CcSEcCtD
Rifaximin—Infestation NOS—Docetaxel—melanoma	0.000439	0.0026	CcSEcCtD
Rifaximin—Infestation—Docetaxel—melanoma	0.000439	0.0026	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000436	0.00258	CcSEcCtD
Rifaximin—Discomfort—Temozolomide—melanoma	0.000434	0.00257	CcSEcCtD
Rifaximin—Decreased appetite—Bleomycin—melanoma	0.000434	0.00257	CcSEcCtD
Rifaximin—Infection—Carmustine—melanoma	0.000433	0.00256	CcSEcCtD
Rifaximin—Dry mouth—Temozolomide—melanoma	0.00043	0.00254	CcSEcCtD
Rifaximin—Pain—Bleomycin—melanoma	0.000427	0.00253	CcSEcCtD
Rifaximin—Confusional state—Temozolomide—melanoma	0.000425	0.00251	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000424	0.00251	CcSEcCtD
Rifaximin—Anaphylactic shock—Temozolomide—melanoma	0.000421	0.00249	CcSEcCtD
Rifaximin—Infection—Temozolomide—melanoma	0.000419	0.00248	CcSEcCtD
Rifaximin—Anorexia—Carmustine—melanoma	0.000416	0.00246	CcSEcCtD
Rifaximin—Epistaxis—Docetaxel—melanoma	0.000414	0.00245	CcSEcCtD
Rifaximin—Nervous system disorder—Temozolomide—melanoma	0.000413	0.00245	CcSEcCtD
Rifaximin—Feeling abnormal—Bleomycin—melanoma	0.000412	0.00244	CcSEcCtD
Rifaximin—Skin disorder—Temozolomide—melanoma	0.000409	0.00242	CcSEcCtD
Rifaximin—Hypotension—Carmustine—melanoma	0.000407	0.00241	CcSEcCtD
Rifaximin—Hyperhidrosis—Temozolomide—melanoma	0.000407	0.00241	CcSEcCtD
Rifaximin—Decreased appetite—Dactinomycin—melanoma	0.000405	0.0024	CcSEcCtD
Rifaximin—Fatigue—Dactinomycin—melanoma	0.000402	0.00238	CcSEcCtD
Rifaximin—Anorexia—Temozolomide—melanoma	0.000402	0.00238	CcSEcCtD
Rifaximin—Pain—Dactinomycin—melanoma	0.000398	0.00236	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Carmustine—melanoma	0.000397	0.00235	CcSEcCtD
Rifaximin—Urticaria—Bleomycin—melanoma	0.000397	0.00235	CcSEcCtD
Rifaximin—Haemoglobin—Docetaxel—melanoma	0.000396	0.00235	CcSEcCtD
Rifaximin—Rhinitis—Docetaxel—melanoma	0.000395	0.00234	CcSEcCtD
Rifaximin—Body temperature increased—Bleomycin—melanoma	0.000395	0.00234	CcSEcCtD
Rifaximin—Haemorrhage—Docetaxel—melanoma	0.000394	0.00233	CcSEcCtD
Rifaximin—Insomnia—Carmustine—melanoma	0.000394	0.00233	CcSEcCtD
Rifaximin—Hypoaesthesia—Docetaxel—melanoma	0.000392	0.00232	CcSEcCtD
Rifaximin—Pharyngitis—Docetaxel—melanoma	0.000391	0.00232	CcSEcCtD
Rifaximin—Urinary tract disorder—Docetaxel—melanoma	0.000389	0.00231	CcSEcCtD
Rifaximin—Dyspnoea—Carmustine—melanoma	0.000389	0.0023	CcSEcCtD
Rifaximin—Oedema peripheral—Docetaxel—melanoma	0.000388	0.0023	CcSEcCtD
Rifaximin—Urethral disorder—Docetaxel—melanoma	0.000387	0.00229	CcSEcCtD
Rifaximin—Feeling abnormal—Dactinomycin—melanoma	0.000384	0.00227	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Temozolomide—melanoma	0.000384	0.00227	CcSEcCtD
Rifaximin—Insomnia—Temozolomide—melanoma	0.000381	0.00226	CcSEcCtD
Rifaximin—Gastrointestinal pain—Dactinomycin—melanoma	0.000381	0.00226	CcSEcCtD
Rifaximin—Decreased appetite—Carmustine—melanoma	0.000379	0.00224	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Carmustine—melanoma	0.000376	0.00223	CcSEcCtD
Rifaximin—Dyspnoea—Temozolomide—melanoma	0.000376	0.00222	CcSEcCtD
Rifaximin—Pain—Carmustine—melanoma	0.000373	0.00221	CcSEcCtD
Rifaximin—Constipation—Carmustine—melanoma	0.000373	0.00221	CcSEcCtD
Rifaximin—Abdominal pain—Dactinomycin—melanoma	0.000368	0.00218	CcSEcCtD
Rifaximin—Body temperature increased—Dactinomycin—melanoma	0.000368	0.00218	CcSEcCtD
Rifaximin—Hypersensitivity—Bleomycin—melanoma	0.000368	0.00218	CcSEcCtD
Rifaximin—Decreased appetite—Temozolomide—melanoma	0.000366	0.00217	CcSEcCtD
Rifaximin—Flushing—Docetaxel—melanoma	0.000366	0.00217	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Temozolomide—melanoma	0.000364	0.00215	CcSEcCtD
Rifaximin—Fatigue—Temozolomide—melanoma	0.000363	0.00215	CcSEcCtD
Rifaximin—Pain—Temozolomide—melanoma	0.00036	0.00213	CcSEcCtD
Rifaximin—Constipation—Temozolomide—melanoma	0.00036	0.00213	CcSEcCtD
Rifaximin—Feeling abnormal—Carmustine—melanoma	0.000359	0.00213	CcSEcCtD
Rifaximin—Asthenia—Bleomycin—melanoma	0.000358	0.00212	CcSEcCtD
Rifaximin—Angiopathy—Docetaxel—melanoma	0.000358	0.00212	CcSEcCtD
Rifaximin—Gastrointestinal pain—Carmustine—melanoma	0.000356	0.00211	CcSEcCtD
Rifaximin—Mediastinal disorder—Docetaxel—melanoma	0.000355	0.0021	CcSEcCtD
Rifaximin—Pruritus—Bleomycin—melanoma	0.000353	0.00209	CcSEcCtD
Rifaximin—Feeling abnormal—Temozolomide—melanoma	0.000347	0.00206	CcSEcCtD
Rifaximin—Mental disorder—Docetaxel—melanoma	0.000345	0.00205	CcSEcCtD
Rifaximin—Abdominal pain—Carmustine—melanoma	0.000345	0.00204	CcSEcCtD
Rifaximin—Body temperature increased—Carmustine—melanoma	0.000345	0.00204	CcSEcCtD
Rifaximin—Gastrointestinal pain—Temozolomide—melanoma	0.000344	0.00204	CcSEcCtD
Rifaximin—Malnutrition—Docetaxel—melanoma	0.000343	0.00203	CcSEcCtD
Rifaximin—Hypersensitivity—Dactinomycin—melanoma	0.000343	0.00203	CcSEcCtD
Rifaximin—Urticaria—Temozolomide—melanoma	0.000335	0.00198	CcSEcCtD
Rifaximin—Asthenia—Dactinomycin—melanoma	0.000334	0.00198	CcSEcCtD
Rifaximin—Body temperature increased—Temozolomide—melanoma	0.000333	0.00197	CcSEcCtD
Rifaximin—Abdominal pain—Temozolomide—melanoma	0.000333	0.00197	CcSEcCtD
Rifaximin—Back pain—Docetaxel—melanoma	0.000332	0.00197	CcSEcCtD
Rifaximin—Muscle spasms—Docetaxel—melanoma	0.00033	0.00195	CcSEcCtD
Rifaximin—Hypersensitivity—Carmustine—melanoma	0.000321	0.0019	CcSEcCtD
Rifaximin—Diarrhoea—Dactinomycin—melanoma	0.000319	0.00189	CcSEcCtD
Rifaximin—Vomiting—Bleomycin—melanoma	0.000318	0.00188	CcSEcCtD
Rifaximin—Anaemia—Docetaxel—melanoma	0.000317	0.00188	CcSEcCtD
Rifaximin—Rash—Bleomycin—melanoma	0.000315	0.00186	CcSEcCtD
Rifaximin—Dermatitis—Bleomycin—melanoma	0.000315	0.00186	CcSEcCtD
Rifaximin—Asthenia—Carmustine—melanoma	0.000313	0.00185	CcSEcCtD
Rifaximin—Hypersensitivity—Temozolomide—melanoma	0.00031	0.00184	CcSEcCtD
Rifaximin—Syncope—Docetaxel—melanoma	0.000308	0.00182	CcSEcCtD
Rifaximin—Asthenia—Temozolomide—melanoma	0.000302	0.00179	CcSEcCtD
Rifaximin—Loss of consciousness—Docetaxel—melanoma	0.000302	0.00179	CcSEcCtD
Rifaximin—Cough—Docetaxel—melanoma	0.0003	0.00177	CcSEcCtD
Rifaximin—Diarrhoea—Carmustine—melanoma	0.000298	0.00177	CcSEcCtD
Rifaximin—Pruritus—Temozolomide—melanoma	0.000298	0.00176	CcSEcCtD
Rifaximin—Nausea—Bleomycin—melanoma	0.000297	0.00176	CcSEcCtD
Rifaximin—Vomiting—Dactinomycin—melanoma	0.000296	0.00175	CcSEcCtD
Rifaximin—Rash—Dactinomycin—melanoma	0.000294	0.00174	CcSEcCtD
Rifaximin—Myalgia—Docetaxel—melanoma	0.000292	0.00173	CcSEcCtD
Rifaximin—Chest pain—Docetaxel—melanoma	0.000292	0.00173	CcSEcCtD
Rifaximin—Arthralgia—Docetaxel—melanoma	0.000292	0.00173	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00029	0.00172	CcSEcCtD
Rifaximin—Dizziness—Carmustine—melanoma	0.000288	0.00171	CcSEcCtD
Rifaximin—Diarrhoea—Temozolomide—melanoma	0.000288	0.00171	CcSEcCtD
Rifaximin—Dry mouth—Docetaxel—melanoma	0.000286	0.00169	CcSEcCtD
Rifaximin—Confusional state—Docetaxel—melanoma	0.000282	0.00167	CcSEcCtD
Rifaximin—Anaphylactic shock—Docetaxel—melanoma	0.00028	0.00166	CcSEcCtD
Rifaximin—Dizziness—Temozolomide—melanoma	0.000279	0.00165	CcSEcCtD
Rifaximin—Infection—Docetaxel—melanoma	0.000278	0.00165	CcSEcCtD
Rifaximin—Vomiting—Carmustine—melanoma	0.000277	0.00164	CcSEcCtD
Rifaximin—Nausea—Dactinomycin—melanoma	0.000277	0.00164	CcSEcCtD
Rifaximin—Shock—Docetaxel—melanoma	0.000276	0.00163	CcSEcCtD
Rifaximin—Rash—Carmustine—melanoma	0.000275	0.00163	CcSEcCtD
Rifaximin—Nervous system disorder—Docetaxel—melanoma	0.000275	0.00163	CcSEcCtD
Rifaximin—Dermatitis—Carmustine—melanoma	0.000275	0.00163	CcSEcCtD
Rifaximin—Headache—Carmustine—melanoma	0.000273	0.00162	CcSEcCtD
Rifaximin—Skin disorder—Docetaxel—melanoma	0.000272	0.00161	CcSEcCtD
Rifaximin—Vomiting—Temozolomide—melanoma	0.000268	0.00159	CcSEcCtD
Rifaximin—Anorexia—Docetaxel—melanoma	0.000267	0.00158	CcSEcCtD
Rifaximin—Rash—Temozolomide—melanoma	0.000266	0.00157	CcSEcCtD
Rifaximin—Dermatitis—Temozolomide—melanoma	0.000265	0.00157	CcSEcCtD
Rifaximin—Headache—Temozolomide—melanoma	0.000264	0.00156	CcSEcCtD
Rifaximin—Hypotension—Docetaxel—melanoma	0.000262	0.00155	CcSEcCtD
Rifaximin—Nausea—Carmustine—melanoma	0.000259	0.00153	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Docetaxel—melanoma	0.000255	0.00151	CcSEcCtD
Rifaximin—Insomnia—Docetaxel—melanoma	0.000253	0.0015	CcSEcCtD
Rifaximin—Nausea—Temozolomide—melanoma	0.00025	0.00148	CcSEcCtD
Rifaximin—Dyspnoea—Docetaxel—melanoma	0.00025	0.00148	CcSEcCtD
Rifaximin—Decreased appetite—Docetaxel—melanoma	0.000244	0.00144	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Docetaxel—melanoma	0.000242	0.00143	CcSEcCtD
Rifaximin—Fatigue—Docetaxel—melanoma	0.000242	0.00143	CcSEcCtD
Rifaximin—Pain—Docetaxel—melanoma	0.00024	0.00142	CcSEcCtD
Rifaximin—Constipation—Docetaxel—melanoma	0.00024	0.00142	CcSEcCtD
Rifaximin—Feeling abnormal—Docetaxel—melanoma	0.000231	0.00137	CcSEcCtD
Rifaximin—Gastrointestinal pain—Docetaxel—melanoma	0.000229	0.00136	CcSEcCtD
Rifaximin—Abdominal pain—Docetaxel—melanoma	0.000221	0.00131	CcSEcCtD
Rifaximin—Body temperature increased—Docetaxel—melanoma	0.000221	0.00131	CcSEcCtD
Rifaximin—Hypersensitivity—Docetaxel—melanoma	0.000206	0.00122	CcSEcCtD
Rifaximin—Asthenia—Docetaxel—melanoma	0.000201	0.00119	CcSEcCtD
Rifaximin—Pruritus—Docetaxel—melanoma	0.000198	0.00117	CcSEcCtD
Rifaximin—Diarrhoea—Docetaxel—melanoma	0.000192	0.00113	CcSEcCtD
Rifaximin—Dizziness—Docetaxel—melanoma	0.000185	0.0011	CcSEcCtD
Rifaximin—Vomiting—Docetaxel—melanoma	0.000178	0.00105	CcSEcCtD
Rifaximin—Rash—Docetaxel—melanoma	0.000177	0.00105	CcSEcCtD
Rifaximin—Dermatitis—Docetaxel—melanoma	0.000176	0.00104	CcSEcCtD
Rifaximin—Headache—Docetaxel—melanoma	0.000176	0.00104	CcSEcCtD
Rifaximin—Nausea—Docetaxel—melanoma	0.000166	0.000985	CcSEcCtD
